Saved in:
| Main Author: | |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2026
|
| Online Access: | https://doi.org/10.5281/zenodo.20313018 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866902076087336960 |
|---|---|
| author | Cojocaru, Cristian Gabriel |
| author_facet | Cojocaru, Cristian Gabriel |
| contents | <p>The EMVA Project introduces a novel system architecture for public preventive health screening through an autonomous, non-invasive kiosk terminal designed for pharmacies and primary care facilities. The system bridges the gap between industrial-grade optical metrology and predictive healthcare triage.</p> <p>Key Technical and Clinical Features:</p> <p>Hardware Integration: The terminal integrates an industrial-grade spectrophotometer into an ergonomic user-facing kiosk, utilizing a precise LED light source to capture diffuse reflectance spectra across the 380 - 730 nm range directly from the user's forearm.</p> <p>Multisystem Triage Capabilities: Rather than focusing on a single pathology, the EMVA cloud-based AI algorithm analyzes the complex optical signatures of dermal tissue to identify early structural, chemical, and vascular biomarkers:</p> <p>Oncology: Mapping early cell texture anomalies, melanin plate alterations, and systemic angiogenic acceleration signals (530 - 580\text{ nm}).</p> <p>Cardiovascular & Circulatory: Detecting peripheral tissue hypoxia and blood oxygenation anomalies via the flattening of the oxyhemoglobin spectral curve 540 - 580 nm).</p> <p>Metabolic & Hepatic: Monitoring advanced glycation end-products (AGEs) (420 - 440 nm) as a pre-diabetes indicator, and tissue bilirubin accumulation (450 - 480nm) to detect early hepatobiliary stress.</p> <p>Operational Stability: Long-term clinical calibration drift is mitigated through autonomous daily reference tile alignments and periodic digital recertification via NetProfiler technology, bypassing the need for factory recalls.</p> <p>Conclusion & Objective:</p> <p>The EMVA Terminal does not serve as a definitive diagnostic tool, but as a high-throughput, non-invasive digital sieve. By generating instant, multi-system health vitality reports during routine pharmacy visits, it flags subclinical anomalies and routes asymptomatic patients to specialist medical practitioners, maximizing the window for 100% successful preventive intervention</p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_20313018 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | EMVA Terminal: An Autonomous Multispectral Screening and Triage System Utilizing High-Resolution Diffuse Reflectance Spectroscopy and Artificial Intelligence Cojocaru, Cristian Gabriel <p>The EMVA Project introduces a novel system architecture for public preventive health screening through an autonomous, non-invasive kiosk terminal designed for pharmacies and primary care facilities. The system bridges the gap between industrial-grade optical metrology and predictive healthcare triage.</p> <p>Key Technical and Clinical Features:</p> <p>Hardware Integration: The terminal integrates an industrial-grade spectrophotometer into an ergonomic user-facing kiosk, utilizing a precise LED light source to capture diffuse reflectance spectra across the 380 - 730 nm range directly from the user's forearm.</p> <p>Multisystem Triage Capabilities: Rather than focusing on a single pathology, the EMVA cloud-based AI algorithm analyzes the complex optical signatures of dermal tissue to identify early structural, chemical, and vascular biomarkers:</p> <p>Oncology: Mapping early cell texture anomalies, melanin plate alterations, and systemic angiogenic acceleration signals (530 - 580\text{ nm}).</p> <p>Cardiovascular & Circulatory: Detecting peripheral tissue hypoxia and blood oxygenation anomalies via the flattening of the oxyhemoglobin spectral curve 540 - 580 nm).</p> <p>Metabolic & Hepatic: Monitoring advanced glycation end-products (AGEs) (420 - 440 nm) as a pre-diabetes indicator, and tissue bilirubin accumulation (450 - 480nm) to detect early hepatobiliary stress.</p> <p>Operational Stability: Long-term clinical calibration drift is mitigated through autonomous daily reference tile alignments and periodic digital recertification via NetProfiler technology, bypassing the need for factory recalls.</p> <p>Conclusion & Objective:</p> <p>The EMVA Terminal does not serve as a definitive diagnostic tool, but as a high-throughput, non-invasive digital sieve. By generating instant, multi-system health vitality reports during routine pharmacy visits, it flags subclinical anomalies and routes asymptomatic patients to specialist medical practitioners, maximizing the window for 100% successful preventive intervention</p> |
| title | EMVA Terminal: An Autonomous Multispectral Screening and Triage System Utilizing High-Resolution Diffuse Reflectance Spectroscopy and Artificial Intelligence |
| url | https://doi.org/10.5281/zenodo.20313018 |